Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 105061732 | 10506173 | 2 | F | 20160624 | 20141009 | 20160630 | EXP | GR-009507513-1410GRC001958 | MERCK | 0.00 | F | Y | 78.00000 | KG | 20160630 | CN | GR | GR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 105061732 | 10506173 | 1 | PS | JANUMET | METFORMIN HYDROCHLORIDESITAGLIPTIN PHOSPHATE | 1 | Oral | 1 TABLET IN THE MORNING AND 1 TABLET AT NIGHT, DAILY (DOSE 1X2) | 22044 | 1 | DF | FILM-COATED TABLET | BID | ||||||
| 105061732 | 10506173 | 2 | C | PRITOR PLUS | TELMISARTAN | 1 | TOTAL DAILY DOSE: 1X1 | U | 0 | ||||||||||
| 105061732 | 10506173 | 3 | C | TENORMIN | ATENOLOL | 1 | 1/2 X2 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 105061732 | 10506173 | 1 | Type 2 diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 105061732 | 10506173 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 105061732 | 10506173 | Breast cancer |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 105061732 | 10506173 | 1 | 2009 | 0 |